GENE EXPRESSION PROFILES ASSOCIATED WITH METASTATIC BREAST CANCER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150184247A1
SERIAL NO

14395759

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A gain-of-function retroviral cDNA screen reveals that Coco, a secreted antagonist of TGF-β ligands, induces solitary mammary carcinoma cells, which have disseminated to others sites and undergone an extended period of dormancy, to exit from dormancy at lung metastatic sites. Evidence indicates that Coco awakens tumor progenitor cells that have extravasated into the lung by inhibiting stroma-derived Bone Morphogenetic Proteins (BMP). Whereas Coco enhances the manifestation of traits associated with cancer stem cells, activation of canonical BMP signaling suppresses these processes. Expression of Coco correlates with lung metastatic capacity in a number of human breast cancer cell lines and induces a gene expression signature that predicts metastatic relapse to the lung but not to the bone in advanced primary tumors. Disclosed herein is the gain-of-function retroviral cDNA screen and a gene signature predictive of selective relapse and gene expression microarrays or panels based thereon for use in prognostication of relapse.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEMORIAL SLOAN-KETTERING CANCER CENTER1275 YORK AVENUE NEW YORK NY 10065

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Giancotti, Filippo G New York, US 4 34

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation